House committee advances bipartisan bill targeting Chinese biotech suppliers

A bill that would ef­fec­tive­ly force dozens of bio­phar­ma com­pa­nies to cut ties with WuXi AppTec and four oth­er Chi­nese biotech sup­pli­ers by 2032 ad­vanced with bi­par­ti­san sup­port in the House Over­sight Com­mit­tee on Wednes­day.

The 40-1 pos­i­tive vote is a key step for­ward for a close­ly-watched bill that has a short time­line to cross the fin­ish line. Both the House and Sen­ate bills are now await­ing floor votes.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.